Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
<p>Table S9 shows the (a) differentially expressed transcripts and (b) altered pathways as identified by GSEA from the ELAVL1 knockdown human primary AML RNA-sequencing data set.</p>
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Awduron Eraill: | , , , , , , , , , , , , , , , , , , , , , |
| Cyhoeddwyd: |
2025
|
| Pynciau: | |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
| _version_ | 1849927640290426880 |
|---|---|
| author | Ana Vujovic (15207479) |
| author2 | Laura de Rooij (15207482) Ava Keyvani Chahi (15207485) He Tian Chen (15207488) Brian A. Yee (15207491) Sampath K. Loganathan (15121740) Lina Liu (15207494) Derek C.H. Chan (15207497) Amanda Tajik (15207500) Emily Tsao (15207503) Steven Moreira (14937143) Pratik Joshi (15207506) Joshua Xu (15207509) Nicholas Wong (15207512) Zaldy Balde (15207515) Soheil Jahangiri (15207518) Sasan Zandi (15207521) Stefan Aigner (15207524) John E. Dick (14937554) Mark D. Minden (14961936) Daniel Schramek (15121764) Gene W. Yeo (15207527) Kristin J. Hope (15207530) |
| author2_role | author author author author author author author author author author author author author author author author author author author author author author |
| author_facet | Ana Vujovic (15207479) Laura de Rooij (15207482) Ava Keyvani Chahi (15207485) He Tian Chen (15207488) Brian A. Yee (15207491) Sampath K. Loganathan (15121740) Lina Liu (15207494) Derek C.H. Chan (15207497) Amanda Tajik (15207500) Emily Tsao (15207503) Steven Moreira (14937143) Pratik Joshi (15207506) Joshua Xu (15207509) Nicholas Wong (15207512) Zaldy Balde (15207515) Soheil Jahangiri (15207518) Sasan Zandi (15207521) Stefan Aigner (15207524) John E. Dick (14937554) Mark D. Minden (14961936) Daniel Schramek (15121764) Gene W. Yeo (15207527) Kristin J. Hope (15207530) |
| author_role | author |
| dc.creator.none.fl_str_mv | Ana Vujovic (15207479) Laura de Rooij (15207482) Ava Keyvani Chahi (15207485) He Tian Chen (15207488) Brian A. Yee (15207491) Sampath K. Loganathan (15121740) Lina Liu (15207494) Derek C.H. Chan (15207497) Amanda Tajik (15207500) Emily Tsao (15207503) Steven Moreira (14937143) Pratik Joshi (15207506) Joshua Xu (15207509) Nicholas Wong (15207512) Zaldy Balde (15207515) Soheil Jahangiri (15207518) Sasan Zandi (15207521) Stefan Aigner (15207524) John E. Dick (14937554) Mark D. Minden (14961936) Daniel Schramek (15121764) Gene W. Yeo (15207527) Kristin J. Hope (15207530) |
| dc.date.none.fl_str_mv | 2025-11-24T22:02:21Z |
| dc.identifier.none.fl_str_mv | 10.1158/2643-3230.30698679 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_S9_from_i_In_Vivo_i_Screening_Unveils_Pervasive_RNA-Binding_Protein_Dependencies_in_Leukemic_Stem_Cells_and_Identifies_ELAVL1_as_a_Therapeutic_Target/30698679 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Targets Oncoprotein & tumor suppressor drug targets Gene Regulation Posttranscriptional and translational control Hematological Cancers Leukemias Oncogenes & Tumor Suppressors Oncogenes Preclinical Models Xenograft models Small Molecule Agents Stem Cell Biology Cancer stem cells Hematopoiesis |
| dc.title.none.fl_str_mv | Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Table S9 shows the (a) differentially expressed transcripts and (b) altered pathways as identified by GSEA from the ELAVL1 knockdown human primary AML RNA-sequencing data set.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_554ae1e8cfcb80743323dedb7bcf03c4 |
| identifier_str_mv | 10.1158/2643-3230.30698679 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30698679 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic TargetAna Vujovic (15207479)Laura de Rooij (15207482)Ava Keyvani Chahi (15207485)He Tian Chen (15207488)Brian A. Yee (15207491)Sampath K. Loganathan (15121740)Lina Liu (15207494)Derek C.H. Chan (15207497)Amanda Tajik (15207500)Emily Tsao (15207503)Steven Moreira (14937143)Pratik Joshi (15207506)Joshua Xu (15207509)Nicholas Wong (15207512)Zaldy Balde (15207515)Soheil Jahangiri (15207518)Sasan Zandi (15207521)Stefan Aigner (15207524)John E. Dick (14937554)Mark D. Minden (14961936)Daniel Schramek (15121764)Gene W. Yeo (15207527)Kristin J. Hope (15207530)CancerCancer BiologyMolecular and Cellular BiologyTherapeutic Research and DevelopmentMethods and TechnologyDrug TargetsOncoprotein & tumor suppressor drug targetsGene RegulationPosttranscriptional and translational controlHematological CancersLeukemiasOncogenes & Tumor SuppressorsOncogenesPreclinical ModelsXenograft modelsSmall Molecule AgentsStem Cell BiologyCancer stem cellsHematopoiesis<p>Table S9 shows the (a) differentially expressed transcripts and (b) altered pathways as identified by GSEA from the ELAVL1 knockdown human primary AML RNA-sequencing data set.</p>2025-11-24T22:02:21ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/2643-3230.30698679https://figshare.com/articles/dataset/Supplementary_Table_S9_from_i_In_Vivo_i_Screening_Unveils_Pervasive_RNA-Binding_Protein_Dependencies_in_Leukemic_Stem_Cells_and_Identifies_ELAVL1_as_a_Therapeutic_Target/30698679CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/306986792025-11-24T22:02:21Z |
| spellingShingle | Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target Ana Vujovic (15207479) Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Targets Oncoprotein & tumor suppressor drug targets Gene Regulation Posttranscriptional and translational control Hematological Cancers Leukemias Oncogenes & Tumor Suppressors Oncogenes Preclinical Models Xenograft models Small Molecule Agents Stem Cell Biology Cancer stem cells Hematopoiesis |
| status_str | publishedVersion |
| title | Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target |
| title_full | Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target |
| title_fullStr | Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target |
| title_full_unstemmed | Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target |
| title_short | Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target |
| title_sort | Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target |
| topic | Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Targets Oncoprotein & tumor suppressor drug targets Gene Regulation Posttranscriptional and translational control Hematological Cancers Leukemias Oncogenes & Tumor Suppressors Oncogenes Preclinical Models Xenograft models Small Molecule Agents Stem Cell Biology Cancer stem cells Hematopoiesis |